1-24-11 Daily Small Cap Market News and Stock Highlights from SmallCapVoice.com

Chip Cutter, AP Business Writer

Intel, technology companies drive up stocks

Technology stocks push markets higher in early trading after Intel raises dividend

NEW YORK (AP) — Technology stocks rose Monday after Intel Corp. raised its quarterly dividend and said it would buy back more of its stock.

The news sent Intel's stock up 1.6 percent to $21.14. Another technology company, graphics chip maker Nvidia Corp., was the biggest gainer in the Standard & Poor's 500 index. Nvidia rose 7 percent to $23.79 after Barrons magazine predicted its stock could rise 80 percent over the next year.

The Dow Jones industrial average rose 24 points, or 0.2 percent, to 11,896 in morning trading.

The Standard & Poor's 500 index rose 1, or 0.1 percent, to 1,285. The Nasdaq composite index rose 4, or 0.2 percent, to 2,694.

Yesterday's Top Performing Small Cap Stock:

Madison Ave. Media, Inc. KHZME

Madison Ave. Media, Inc. was a SmallCapVoice.com top performer closing up over 25% on trading volume of 49,177 shares.

Madison Ave. Media is an advanced digital media company that offers a differentiated and competitive array of marketing technologies and services to clients in multiple industries. Their technology and services bring advanced, highly productive marketing, communications and advertising solutions to clients. And their services address the complete digital media value chain, combining the best practices of traditional media support with the power of technology.

Detailed Quote >>

Today's SmallCapVoice.com Hot Stock to Watch:

XZERES Wind Corp. XWND

In a New Audio Interview at SmallCapVoice.com, XZERES Wind Corporation's CEO, Frank Greco, Provides Details Regarding Recent News

AUSTIN, Texas–(BUSINESS WIRE)– SmallCapVoice.com, Inc. announces today that a new audio interview with XZERES Wind Corporation (OTC BB:XWND), designer, developer and producer of distributed generation, wind power systems for the small wind market (2.5kW-100kW), is now available. The interview can be heard at http://smallcapvoice.com/blog/1-21-11-audio-interview-with-xzeres-wind-corp-otccb-xwnd.

Other Small Cap News

Richmont Mines Inc. (NYSE Amex: RIC)

Richmont 2010 Gold Sales Increase 14%; Company Provides 2011 Production Forecasts and Updated Reserve and Resource Calculations

On a consolidated basis, Richmont Mines sold 68,123 ounces of gold in 2010, a notable 14% increase over 2009 sales levels of 59,733 ounces of gold, and 5% above the Company's targeted level of 65,000 ounces of gold for the year. On a segmented basis, the Island Gold Mine contributed 45,865 ounces of gold in 2010, 18% above 2009 levels, while the Beaufor Mine sold 22,258 ounces of gold in 2010, up 7% over the prior year's levels.

Immunomedics, Inc. IMMU

Immunomedics Reports Targeted Therapy for Advanced Pancreatic Cancer Improves Survival

Results From Multicenter Phase Ib/II Study Presented at 2011 Gastrointestinal Cancers Symposium

SAN FRANCISCO, Jan. 21, 2011 (GLOBE NEWSWIRE) — Immunomedics, Inc. IMMU, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that repeated therapy cycles of its proprietary antibody, clivatuzumab tetraxetan, labeled with yttrium-90 (Y-90) plus low-dose gemcitabine at 200 mg/m2, extended median overall survival (OS) to 11.8 months, more than double the 5.4 months OS in patients treated with a single cycle. Increased Y-90 doses also improved responses; patients receiving a dose of 12 mCi/m2 or higher once a week for 3 weeks reporting a median OS of 8.0 months versus 6.0 months at doses of 9 mCi/m2 or less, once a week for 3 weeks.

PharmAthene, Inc. (NYSE Amex: PIP)

PharmAthene Provides Update on Litigation With SIGA Technologies

ANNAPOLIS, Md., Jan. 24, 2011 /PRNewswire/ — PharmAthene, Inc. (NYSE Amex: PIP) announced today that the trial in the Delaware Court of Chancery, which commenced January 3, 2011, in its breach of contract action against SIGA Technologies concluded this past Friday, January 21, 2011. The Company anticipates that post trial briefs in the case and subsequent oral argument in front of the court will be complete by the end of April 2011.

Level 3 Communications LVLT

Level 3 Announces Private Debt for Debt Exchange

Transaction will retire Level 3's outstanding 9% Convertible Senior Discount Notes due 2013

BROOMFIELD, Colo.–(BUSINESS WIRE)– Level 3 Communications, Inc. LVLT (the “Company”) today announced it has agreed to issue $300,217,000 aggregate principal amount of its 11.875% Senior Notes due 2019 to an institutional investor in exchange for $294,732,000 aggregate principal amount of the Company's outstanding 9% Convertible Senior Discount Notes due 2013 in a private transaction. The Company anticipates closing the transaction by the end of January, subject to customary closing conditions.

Immunomedics, Inc. IMMU

Immunomedics Reports First Experimental Studies Combining Antibody-Drug Conjugate With Antibody-Directed Radiation Therapy for Pancreatic Cancer

SAN FRANCISCO, Jan. 24, 2011 (GLOBE NEWSWIRE) — Immunomedics, Inc. IMMU, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that combining antibody-directed drug and radionuclide therapeutics for pancreatic cancer improved efficacy in preclinical studies with minimal toxicity. Results from these investigations were presented at the 2011 Gastrointestinal Cancers Symposium.

Alexza Pharmaceuticals, Inc. ALXA

British Journal of Psychiatry Publishes Results from Phase 3 Study of Alexza's AZ-004 for the Treatment of Agitation in Patients with Schizophrenia

AZ-004 was safe and well tolerated in this study

“Individuals with schizophrenia are highly vulnerable to episodes of agitation. Current treatment options are not optimal for managing these episodes,” commented Dr. Michael D. Lesem, the publication's lead author, a principal investigator for the Phase 3 trial and Medical Director at Claghorn-Lesem Research Clinic, Houston, Texas. “There is a clear need for novel anti-agitation treatments that are quick to act, safe and well tolerated, easy to administer and accepted by patients and staff. In this study, inhaled loxapine provided a rapidly calming effect in agitated patients with schizophrenia.”

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide. Known for its ability to help emerging growth companies build a following among retail and institutional investors, SmallCapVoice.com utilizes its stock newsletter to feature its audio interviews, as well small cap company's financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the stocks they are interested in. Tools like our stock charts, stock alerts, and our company information sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets.

The SmallCapVoice.com, Inc. Daily Highlights is an electronic publication, and is for informational purposes only. The Small Cap Voice Daily Highlights covers both client and non client issuers. Non client issuer's news is listed under other small cap news. SmallCapVoice is an electronic publication providing information on selected public companies. All companies profiled on this website pay cash or restricted stock to SmallCapVoice as consideration for the electronic dissemination of the company's information and our comments about the company. Section 17(b) of the Securities Act of 1933 requires that SmallCapVoice fully disclose the type consideration (i.e. cash, restricted stock, and restricted stock with registration rights, stock options, stock warrants, or other type consideration) and the specific amount of the consideration our company receives or will receive, directly or indirectly, from an issuer, underwriter, or dealer. No information contained in our website, e-mail communications or our publications should be considered as a solicitation to purchase or sell the securities of the profiled companies. SmallCapVoice is not a registered investment advisor or a registered securities broker dealer. We do not undertake or represent to make investment recommendations or to give advice pertaining to the purchase or sale of the securities mentioned in our web site, e-mail communications or publications. The information contained in our website, e-mail communications and publications are carefully compiled by SmallCapVoice from public sources that we believe to be reliable. SmallCapVoice, however, does not guarantee the accuracy of any information contained in our website, e-mail communications or publications. This material is not a substitute for either one's own thorough investigation of an investment opportunity or the exercise of good business judgment. SmallCapVoice does not endorse, independently verify, or assert the truthfulness or reliability of any statements or data obtained from third party sources that are published by us about the profiled companies in our website articles, e-mail communications or publications, but we do not publish information that we know is incorrect. Investors should not rely solely on the information contained in our website, e-mail communications or publications when making investment decisions. Instead, investors should use the information provided on the profiled companies as a starting point for conducting additional research that will permit them to form their own opinions regarding the appropriateness of an investment in the profiled company's securities. SmallCapVoice does not warrant, represent or guaranty that there has been no change in the affairs of the profiled company since the date that information was published on this website, in e-mail communications or in our publications regarding a profiled company or after the date of the profiled company's press releases or other information disseminated via our website or publications. If you become aware of any change of circumstances related to any website article, e-mail communication or publication, please notify us immediately. See the Contact Us page for the appropriate e-mail address. The information contained in our website, e-mail communications and publications pertains to microcap, small cap and/or other thinly traded securities which by their very nature involve an extremely high degree of risk. An investment in these type of securities could result in the loss of some or all of an investment in the company. In addition, due to the illiquid nature of some of these securities, an investor may find encounter difficulties in liquidating the securities. SmallCapVoice may liquidate the stock consideration it receives at any time it deems it appropriate to do so after the required six-month holding period has run after the completion of the services for which SmallCapVoice was paid in stock. The liquidation of our stock may have a negative impact on the securities of the company liquidated, including decreased market value and/or dilution of the company's securities. The following companies have paid, and/or have agreed to pay SmallCapVoice to: distribute the company's information and reports on this website, to send e-mail communications; to send publications by mail, to post company Internet links on our website, and to compile and/or to distribute reports in an e-mail newsletter.

We encourage our readers to use caution when investing and educate themselves at the web sites of the Securities and Exchange Commission (“SEC”) at www.sec.gov and/or the National Association of Securities Dealers (“NASD”) at www.nasd.com. We encourage you to study the SEC's policies regarding online newsletters at http://www.sec.gov/answers/newsltr.htm. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at www.sec.gov/consumer/cyberfr.htm. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our site.

Contact:

Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
http://www.smallcapvoice.com